v3.26.1
Stockholders' Equity (Tables)
12 Months Ended
Mar. 31, 2026
Stockholders' Equity Note [Abstract]  
Schedule of reconciliation of warrants outstanding

A reconciliation of the beginning and ending balances of warrants outstanding is as follows:

 

 

 

Number of Shares

 

Warrants outstanding as of March 31, 2024

 

 

2,666,667

 

Warrants exercised

 

 

(12,500

)

Warrants outstanding as of March 31, 2025

 

 

2,654,167

 

Warrants exercised

 

 

(1,947,500

)

Warrants outstanding as of March 31, 2026

 

 

706,667

 

Schedule of analysis of option activity

As of March 31, 2025

 

Min

 

 

Max

 

 

Options Outstanding

 

 

Weighted Average Remaining Life in Years

 

 

Weighted Average Exercise Price

 

 

Aggregate Intrinsic Value

 

$

148.0

 

 

$

148.0

 

 

 

250

 

 

 

0.25

 

 

$

148

 

 

$

 

 

 

 

 

 

250

 

 

 

0.25

 

 

$

148

 

 

$

 

Schedule of weighted average assumptions used to estimate fair value of SARs

The following weighted average assumptions were used to estimate the fair value of SARs granted, as follows:

 

 

 

For the Year Ended March 31,

 

 

 

2026

 

Expected dividend yield

 

$

 

Expected equity volatility

 

 

100

%

Expected term (years)

 

 

3.0

 

Risk-free interest rate

 

 

3.92

%

Exercise price

 

$

3.16

 

Market price per share

 

$

3.16

 

Schedule of stock appreciation rights outstanding

SARs outstanding under the 2017 Plan, along with the minimum and maximum strike price of each group, are as follows:

 

As of March 31, 2026

 

Min

 

 

Max

 

 

SARs Outstanding
(In thousands)

 

 

Weighted Average Remaining Life in Years

 

 

Weighted Average Exercise Price

 

 

Aggregate Intrinsic Value
(In thousands)

 

$

3.16

 

 

$

3.16

 

 

 

85

 

 

 

9.01

 

 

$

3.16

 

 

$

 

$

5.80

 

 

$

12.80

 

 

 

625

 

 

 

5.98

 

 

$

9.40

 

 

 

 

$

23.20

 

 

$

29.40

 

 

 

98

 

 

 

3.12

 

 

$

27.77

 

 

 

 

$

39.40

 

 

$

44.60

 

 

 

38

 

 

 

4.89

 

 

$

39.43

 

 

 

 

 

 

 

 

 

 

 

846

 

 

 

5.91

 

 

$

12.24

 

 

$

 

 

As of March 31, 2025

 

Min

 

 

Max

 

 

SARs Outstanding
(In thousands)

 

 

Weighted Average Remaining Life in Years

 

 

Weighted Average Exercise Price

 

 

Aggregate Intrinsic Value
(In thousands)

 

$

5.80

 

 

$

12.80

 

 

 

628

 

 

 

6.92

 

 

$

9.44

 

 

$

 

$

23.20

 

 

$

29.40

 

 

 

98

 

 

 

4.12

 

 

$

27.77

 

 

 

 

$

39.40

 

 

$

46.40

 

 

 

41

 

 

 

5.85

 

 

$

39.18

 

 

 

 

 

 

 

 

 

 

 

766

 

 

 

6.51

 

 

$

13.36

 

 

$

 

 

Exercisable SARs under the 2017 Plan as of March 31, 2026 are as follows:

SARs Exercisable
(In thousands)

 

 

Weighted Average
Remaining Life in Years

 

 

Weighted Average
Exercise Price

 

 

Aggregate Intrinsic Value
(In thousands)

 

 

691

 

 

 

6.1

 

 

$

14.05

 

 

$

 

Schedule of SARs outstanding

Activity for the year ended March 31, 2026 is as follows (in thousands):

 

 

 

Year Ended
March 31, 2026

 

 SARs Outstanding March 31, 2025

 

 

766

 

 Issued

 

 

85

 

 Forfeited

 

 

(5

)

 Total SARs Outstanding March 31, 2026

 

 

846

 

 

Schedule of RSA/RSU activity

RSU and RSA activity for the year ended March 31, 2026 is as follows (in thousands):

 

 

 

Year Ended
March 31, 2026

 

 

Weighted Average Grant Date Fair Value

 

 

Aggregate Fair Value

 

 Outstanding March 31, 2025

 

 

2,255

 

 

$

0.83

 

 

$

1,872

 

 Issued

 

 

998

 

 

 

3.21

 

 

 

3,202

 

 Forfeited

 

 

(170

)

 

 

0.83

 

 

 

(141

)

 Outstanding March 31, 2026

 

 

3,083

 

 

$

1.60

 

 

$

4,933